Leptin receptor affinity peptide and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- DUBU BIOSCIENCES
- Publication Date
- 2021-08-13
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to a Leptin receptor affinity peptide, in particular to a Leptin receptor affinity peptide capable of specifically binding to mesenchymal stem cells (MSCs) and a screening method thereof, which is applied to tissue engineering repair and belongs to biomedical technology field. Background technique
[0002] Mesenchymal stem cells (MSCs), mainly derived from mesoderm, are a type of adult stem cells with high self-renewal ability and differentiation potential, and are important members of the stem cell family. MSCs were first discovered in the bone marrow, and later studies found that MSCs mainly exist in the connective tissue of the whole body and the interstitium of organs. At present, MSCs can be isolated and prepared from bone marrow, placenta, umbilical cord, fat and other tissues. Based on the multi-differentiation potential of MSC, it can be directed to differentiate into bone, cartilage, fat, cardiac muscle and other tissue ...